Scientific and Medical Equipment House Company
4014.SRSAUHealthcare● Active
$31.50
$-0.10(-0.32%)
Market Cap$945000000
P/E Ratio—
52W High$41
52W Low$26
Scientific and Medical Equipment House Company (4014.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4014.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.03B | $0.04B | $0.05B | $0.02B | $0.08B |
| Depreciation & Amort. | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.07B) | $0.20B | ($0.26B) | $0.03B | ($0.19B) |
| Net Cash from Operations | ($0.01B) | $0.29B | ($0.14B) | $0.12B | ($0.08B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.00B) | ($0.01B) | ($0.02B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Net Cash from Investing | ($0.01B) | ($0.00B) | ($0.01B) | ($0.02B) | $0.00B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.03B) | ($0.03B) | $0.00B | ($0.02B) | ($0.03B) |
| Debt Issued / Repaid | ($0.02B) | ($0.15B) | $0.15B | ($0.07B) | $0.07B |
| Net Cash from Financing | ($0.05B) | ($0.21B) | $0.12B | ($0.10B) | $0.04B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.01B) | $0.29B | ($0.16B) | $0.11B | ($0.09B) |
| FCF Margin %(computed) | -1.46% | 32.58% | -19.46% | 14.88% | -13.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Scientific and Medical Equipment House Company data
About Scientific and Medical Equipment House Company (4014.SR) Cash Flow Statement
Scientific and Medical Equipment House Company generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -1.46%. Capital expenditure was ($0.01B).
Frequently asked questions
4014.SR · 4 questionsScientific and Medical Equipment House Company generated free cash flow of ($0.01B) for 2025, down 104.5% year-over-year.
4014.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15